GlassScriptPhysician profile
Bryan Mcdonald
NPI 1215098322
$357.50
in general payments reported to CMS, 2019-2025
10 companies · $44.99 in 2025
The $44.99 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.35 · 2021: $36.54 · 2022: $168 · 2023: $30.88 · 2024: $16.98 · 2025: $44.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $154.74 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $36.49 | 2021-2023 | |
| Cranial Technologies, INC | $30.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.65 | 2023-2024 | Flumist Quadrivalent |
| Integra Lifesciences Corporation | $26.56 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Alk-Abello, INC | $18.43 | 2025 | Neffy |
| Cognoa, INC. | $17.26 | 2021 | |
| Kaleo, INC. | $17.00 | 2019 | |
| Merck Sharp & Dohme LLC | $13.02 | 2022 | |
| Shire North American Group INC | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.